Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: October 7, 2022

Estramustine phosphate sodium - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What are the generic drug sources for estramustine phosphate sodium and what is the scope of patent protection?

Estramustine phosphate sodium is the generic ingredient in one branded drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for estramustine phosphate sodium. One supplier is listed for this compound.

Summary for estramustine phosphate sodium
Recent Clinical Trials for estramustine phosphate sodium

Identify potential brand extensions & 505(b)(2) entrants

University of Massachusetts, WorcesterPhase 2
National Institutes of Health Clinical Center (CC)Phase 2
Dana-Farber Cancer InstitutePhase 2

See all estramustine phosphate sodium clinical trials

Pharmacology for estramustine phosphate sodium
Drug Class Alkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for estramustine phosphate sodium
Anatomical Therapeutic Chemical (ATC) Classes for estramustine phosphate sodium

US Patents and Regulatory Information for estramustine phosphate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn EMCYT estramustine phosphate sodium CAPSULE;ORAL 018045-001 Approved Prior to Jan 1, 1982 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.